BRIGHTMIND.AI
LIVE

Serial Number

79369271

Owner

Brightmind.AI GmbH

Attorney

Jeremy Peter Green Eche

Filing Date

Mar 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BRIGHTMIND.AI Trademark

Serial Number: 79369271 • Registration: 7525621

BRIGHTMIND.AI is a trademark filed by Brightmind.AI GmbH on March 3, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Brightmind.AI GmbH

Maria-Theresien-Straße 32/29

Entity Type: 27

Trademark Details

Filing Date

March 3, 2023

Registration Date

October 8, 2024

Published for Opposition

July 23, 2024

Goods & Services

Low-frequency electromagnetic therapy apparatus; transcutaneous electrical nerve stimulators; transcutaneous electrical nerve stimulation apparatus; diagnostic apparatus for medical purposes for testing neurological conditions; medical electrodes; medical instruments, namely, transcranial magnetic stimulation (TMS) apparatus, electroencephalography (EEG) apparatus, neurostimulators, brain-computer interface (BCI) apparatus; medical apparatus; testing apparatus for medical purposes; apparatus for analyzing brain wave frequencies; apparatus for the diagnosis of cerebrovascular diseases; brain pacemakers; transcutaneous electrical nerve stimulation electrodes; electrotherapy stimulation apparatus comprising electrical nerve stimulators; electrical apparatus for nerve stimulation for rehabilitative and pain management, disease modifying, stabilization and improvement in neurological and psychiatric conditions purposes; electronic nerve stimulators for medical use; apparatus for nerve location, namely, transcranial magnetic stimulation (TMS) apparatus; neural helmets for medical purposes; medical apparatus for neurographic purposes, namely, electroencephalography (EEG) apparatus; apparatus for the diagnosis of neurological diseases; medical apparatus and instruments relating to neurovegetative reactivity

Data mining; development and testing of computing methods, algorithms and software; platform as a service (PAAS) services featuring software platforms for AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; software as a service (SAAS) services featuring software for AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; computer software development; research and development of new products; medical and scientific research, namely, conducting clinical trials for others; scientific research and development; scientific research for medical purposes in the field of neurological and psychiatric disorders; research in the field of artificial intelligence technology; platforms for artificial intelligence as software as a service (SAAS) services featuring computer software platforms for {AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; medical research; technological research in the field of {neurological and psychiatric disorders; software as a service (SAAS) services featuring software for deep neural networks; software as a service (SAAS) services featuring software for machine learning, deep learning and deep neural networks

Electromagnetic coils; electronic databases in the field of neuromodulation in neurological diseases recorded on computer media; downloadable computer software programs for patient profiling and neurological disease management; apparatus and instruments for research purposes, namely, electroencephalography (EEG) apparatus, neurostimulators and brain-computer interface (BCI) apparatus; electronic control instruments for influencing and interacting of the human brain; neural helmets, not for medical purposes; digital sensors for detecting brain waves and health parameters; downloadable artificial intelligence software for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence software for use in the field of healthcare, namely, for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence and machine learning software for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence software for analysis of personal health and lifestyle data; downloadable software for the integration of artificial intelligence and machine learning in the field of Big Data

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 17, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 17, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 8, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 8, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 8, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 20, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 20, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 20, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 20, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 6, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 12, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 12, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 27, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 2, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 16, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 11, 2023 REPR